Fucose-specific conjugation of hydrazide derivatives to a vascular-targeting monoclonal antibody in IgG format

Kathrin Zuberbühler1, Giulio Casi, Gonçalo J L Bernardes

  • 1Department of Chemistry and Applied Biosciences, Swiss Federal Institute of Technology (ETH Zürich), Wolfgang-Pauli Str. 10, 8093 Zürich, Switzerland.

Chemical Communications (Cambridge, England)
|June 12, 2012
PubMed

We describe a method that enables specific and efficient conjugation of hydrazide-moieties to an IgG targeting the tumor neovasculature. The resulting chemically defined, homogeneous hydrazone-linked IgG conjugates remain immunoreactive and have a half-life of approximately 18 hours at physiological pH and temperature suitable for localized delivery of toxic drugs.